SANTOS DA SILVA JORGE (Chief Executive Officer) sold 6.5% of their position (200K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $2.97M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/10/2025ACC: 0001213900-25-120106
DirectorOfficer· Chief Executive Officer
Since Apr 2022
-200K
Net shares
Net seller
$2.97M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
200K disposed
Non-Derivative Transactions2
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−130K
Price / share
$15.08
Trade value
$1.96M
% of position
4.2%
12/8/2025
3.08M→2.95M
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−70K
Price / share
$14.49
Trade value
$1.01M
% of position
2.4%
12/9/2025
2.95M→2.88M
Total
Net shares
−200K
Net value
-$2.97M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 12/8/2025 | S · Sale | −130K | $15.08 | $1.96M | 4.2% | 3.08M | 2.95M |
| Class A ordinary shares, par value $0.0001 per share Direct | 12/9/2025 | S · Sale | −70K | $14.49 | $1.01M | 2.4% | 2.95M | 2.88M |
| Total | −200K | -$2.97M | ||||||
Derivative Transactions0
No derivative transactions reported